Therapeutic Approach

Archive: November, 2010

Ritter Pharmaceuticals, Inc. Awarded a Grant under the U.S. Qualified Therapeutic Discovery Project Program

LOS ANGELES – November 2, 2010 – Ritter Pharmaceuticals, Inc., a biological therapeutics company with a focus on digestive diseases, announced today that it has been awarded a grant by the United States government program, the Qualifying Therapeutic Discovery Project (QTDP).The QTDP grant supports the development of Ritter Pharmaceuticals’ flagship product, RP-G28, as a treatment [...]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD